Clinical Trials Browser

OTHER × Recurrence × Panitumumab × Clear all

NCT01504477 2020-03-16

Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

Phase 1/2 Terminated

6 enrolled 8 charts

Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT01388621 2013-08-20

PROVE

Phase 2 Unknown

Ovarian Neoplasms, Recurrence